Not Tagged
Not Tagged
['tnbc', 'congrat', 'gim2', '#gi', 'confirm,(-confirma),(-confirme),(-confirmi)']
#gim2 trial confirms the benefit of dose-dense chemotherapy for high risk early stage bc, specially in tnbc. more strikingly, after 15 years about 40% of patients will relapse! long-term fu is critical in bc clinical trials; congrats for the italian group #esmo2022 
Medical Oncologist, Breast Cancer Program at Hospital Moinhos de Vento, Clinical Investigator at Hospital São Lucas @PUCRS, Chair @Lacog_group